A detailed history of Mayfair Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mayfair Advisory Group, LLC holds 1,463 shares of LLY stock, worth $1.3 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
1,463
Previous 1,489 1.75%
Holding current value
$1.3 Million
Previous $1.16 Million 14.34%
% of portfolio
0.94%
Previous 0.85%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $18,846 - $23,635
-26 Reduced 1.75%
1,463 $1.32 Million
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $47,376 - $63,382
80 Added 5.68%
1,489 $1.16 Million
Q4 2023

Jan 19, 2024

BUY
$525.19 - $619.13 $6,302 - $7,429
12 Added 0.86%
1,409 $821,000
Q1 2023

Apr 20, 2023

SELL
$310.63 - $364.82 $17,084 - $20,065
-55 Reduced 3.79%
1,397 $479,000
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $17,685 - $20,606
55 Added 3.94%
1,452 $0
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $163,064 - $185,828
-550 Reduced 28.25%
1,397 $449,000
Q1 2022

Apr 14, 2022

BUY
$234.69 - $291.66 $37,081 - $46,082
158 Added 8.83%
1,947 $570,000
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $7,869 - $9,766
35 Added 2.0%
1,789 $466,000
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $6,138 - $7,940
34 Added 1.98%
1,754 $403,000
Q4 2020

Jan 28, 2021

BUY
$130.46 - $172.63 $1,826 - $2,416
14 Added 0.82%
1,720 $290,000
Q2 2020

Jul 13, 2020

BUY
$136.42 - $164.18 $232,732 - $280,091
1,706 New
1,706 $280,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mayfair Advisory Group, LLC Portfolio

Follow Mayfair Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayfair Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayfair Advisory Group, LLC with notifications on news.